Has Nichole Orofino received payments from drug or device companies?

Yes. Drug and device makers reported $4,899 in general payments to Nichole Orofino across 337 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Nichole Orofino did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Nichole Orofino come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Nichole Orofino

Psychiatric/Mental Health · Auburn, NYNPI 1396449286

Payments from drug & device makers

$4,899in general payments, 2019–2025

Across 337 payments — averaging $14.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$1K
Teva Pharmaceuticals USA, Inc.$828
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$547
Johnson & Johnson$455
Neurocrine Biosciences, Inc.$448
Alkermes, Inc.$401
plus $1K from 11 others

What the payments were for

Food & beverage$4,899100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	64	$1,029
Teva Pharmaceuticals USA, Inc.	75	$828
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	31	$547
Johnson & Johnson	17	$455
Neurocrine Biosciences, Inc.	54	$448
Alkermes, Inc.	24	$401
E.r. Squibb & Sons, L.L.C.	22	$220
Vanda Pharmaceuticals Inc.	9	$214
Otsuka America Pharmaceutical, Inc.	14	$213
Axsome Therapeutics, Inc.	4	$186
Indivior Inc.	12	$173
Takeda Pharmaceuticals U.S.A., Inc.	3	$57
Lundbeck LLC	2	$44
Supernus Pharmaceuticals, Inc.	2	$32
Gilead	1	$20
Collegium Pharmaceutical, Inc.	1	$19
Corium, LLC	2	$15

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,899 in reported general payments places this provider in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	17	$22,393
RexultiBrexpiprazole	13	$18,159
AbilifyAripiprazole	12	$9,484
Quetiapine Fumarate	39	$1,759
Divalproex Sodium	32	$1,747
Sertraline Hcl	60	$767
Buspirone Hcl	40	$726
Aripiprazole	16	$618
Duloxetine Hcl	43	$610
Mirtazapine	38	$511
Venlafaxine Hcl ErVenlafaxine Hcl	35	$494
Olanzapine	17	$487
Bupropion XlBupropion Hcl	29	$432
Trazodone Hcl	56	$375
Risperidone	13	$322

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$1,029	$22,39317 claims
Otsuka America Pharmaceutical, Inc.Rexulti	$213	$18,15913 claims
E.r. Squibb & Sons, L.L.C.Abilify	$220	$9,48412 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Auburn

Andrew CataloneAuburn$26K
Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Mary OlsonNew York$142K
Elijah StevensBinghamton$131K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →